AusPAR: Imatinib

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

31 March 2014
AusPAR Details
AusPAR
AusPAR: Imatinib (pdf, 1 MB)
AusPAR: Imatinib (docx, 2 MB)
Attachment: Product Information: Imatinib (pdf, 714 KB)
Attachment: Product Information: Imatinib (docx, 1005 KB)
Attachment: Extract from Clinical Evaluation Report: Imatinib (pdf, 2 MB)
Attachment 2. Extract from the Clinical Evaluation Report for iamtinib mesylate (docx, 3 MB)
Active Ingredient
Imatinib
Product Name
Glivec
Sponsor
Novartis Pharmaceuticals Australia Pty Limited
Submission Number
PM-2012-02722-3-4
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
22 January 2014
Publication Date

31 March 2014
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/816